From advice on choosing the correct magnetic bead to the benefits of lyophilization, find out how we can help you commercialize your assays faster. With technical expertise and extensive manufacturing capabilities supported by security of supply commitments we can provide validated solutions which minimize disruption to your molecular diagnostics workflows.
Next-generation sequencing (NGS) supports a diverse range of applications including clinical diagnostics, disease risk, and therapeutic interventions. We are advancing the simplification and accessibility of the NGS technologies for day-to-day research, clinical diagnostics and much more. Find out about the developing technologies and the products available to support your workflows.
Almost all protein samples need further preparation after collection which can be critical to successful downstream analysis. Within immunodiagnostics, pharma development and other proteomics fields, there is increasing demand for high-quality, small scale protein preparation for analytical purposes. Find out about the products and services available to optimize immunology and protein purification as a diagnostic tool.
This handbook is for students and experienced practitioners in the protein research field who have an interest in “getting it right from the start.” Gain a deep understanding of the important considerations in the design process of sample preparation operations, sample types and preparation techniques.
Save 20% on your next purchase. Enter SMS20 at the checkout
Save 20% on your next purchase. Enter SSIL20 at the checkout.
Save 20% on your next purchase. Enter GENOMIPHI20 at the checkout
Save 20% on your next purchase. Enter TEMPLIPHI20 at the checkout
Save 20% on your next purchase. Enter SXCF20 at the checkout
Reproductive health, oncology, Mendelian diseases, complex diseases, and infectious diseases are key areas where next-generation sequencing (NGS) has a significant presence or is expected to establish itself in the coming years. Explore the genetic screening approaches that have led to more detailed data, better diagnoses, and more targeted treatments in this white paper.
Precision health is a broad, personalized approach to disease prevention, diagnosis, treatment, and monitoring. Explore the role of molecular diagnostic assay technologies, such as FISH, PCR, microarrays, and sequencing, that support precision health with detailed data on genetic markers of disease.
Cell-free DNA (cfDNA) is currently trending as a biomarker from liquid biopsy in several clinical applications, including oncology, organ and transplant medicine, and non-invasive prenatal testing (NIPT). This white paper discusses the challenges and opportunities in measuring cfDNA from liquid samples.
Recent technological advancements have made single-cell sequencing an increasingly powerful tool for diagnosis, treatment response prediction, and treatment selection for cancer. Today tens of thousands of individual cells from a single sample or patient can be analyzed, giving researchers an unprecedented opportunity to understand individual cell populations and their behavior in diseased tissue.
Advances in third generation (or long-read) sequencing are now providing solutions to the difficult questions in cell biology, disease research, and agrigenomics, giving insight into obscure genomic regions unreachable by existing short read NGS methods. So, what does the future hold? Find out in our whitepaper.
